- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
- Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
- Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
Key statistics
On Friday, Sarepta Therapeutics Inc (AB3A:STU) closed at 114.90, -11.62% below its 52-week high of 130.00, set on Feb 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 115.95 |
---|---|
High | 115.95 |
Low | 114.90 |
Bid | 113.60 |
Offer | 115.05 |
Previous close | 110.40 |
Average volume | 0.00 |
---|---|
Shares outstanding | 94.52m |
Free float | 89.83m |
P/E (TTM) | 1,541.86 |
Market cap | 11.61bn USD |
EPS (TTM) | 0.0797 USD |
Data delayed at least 15 minutes, as of Jun 14 2024.
More ▼